Azurrx Biopharma Inc (AZRX) Fundamental Analysis & Valuation

NASDAQ:AZRX

Current stock price

3.45
+0.07 (+2.07%)
At close:
3.42
-0.03 (-0.87%)
After Hours:

This AZRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. AZRX Profitability Analysis

1.1 Basic Checks

  • In the past year AZRX has reported negative net income.

1.2 Ratios

Industry RankSector Rank
ROA -288.01%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

  • AZRX does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. AZRX Health Analysis

2.1 Basic Checks

  • There is no outstanding debt for AZRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

  • AZRX has an Altman-Z score of -18.16. This is a bad value and indicates that AZRX is not financially healthy and even has some risk of bankruptcy.
  • There is no outstanding debt for AZRX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.16
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

  • A Current Ratio of 1.33 indicates that AZRX should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.33 indicates that AZRX should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. AZRX Growth Analysis

3.1 Past

  • AZRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -32.56%.
EPS 1Y (TTM)-32.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 11.05% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y52.24%
EPS Next 2Y28.65%
EPS Next 3Y20.55%
EPS Next 5Y11.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AZRX Yearly Revenue VS EstimatesAZRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 5M 10M 15M
AZRX Yearly EPS VS EstimatesAZRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -1 -2 -3

More info and screens

Find the best growth stocksShow best growing peers

1

4. AZRX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AZRX. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AZRX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AZRX Price Earnings VS Forward Price EarningsAZRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.63
AZRX Per share dataAZRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

  • AZRX's earnings are expected to grow with 20.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y28.65%
EPS Next 3Y20.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. AZRX Dividend Analysis

5.1 Amount

  • No dividends for AZRX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

AZRX Fundamentals: All Metrics, Ratios and Statistics

Azurrx Biopharma Inc

NASDAQ:AZRX (9/21/2021, 8:00:01 PM)

After market: 3.42 -0.03 (-0.87%)

3.45

+0.07 (+2.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners0.11%
Inst Owner Change0%
Ins Owners23.96%
Ins Owner Change0%
Market Cap32.17M
Revenue(TTM)N/A
Net Income(TTM)-39.68M
Analysts90
Price Target3.4 (-1.45%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 4.57
P/tB N/A
EV/EBITDA -0.63
EPS(TTM)-0.78
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.75
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -288.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z -18.16
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-32.56%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5.88%
EPS Next Y52.24%
EPS Next 2Y28.65%
EPS Next 3Y20.55%
EPS Next 5Y11.05%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

Azurrx Biopharma Inc / AZRX Fundamental Analysis FAQ

What is the fundamental rating for AZRX stock?

ChartMill assigns a fundamental rating of 1 / 10 to AZRX.


Can you provide the valuation status for Azurrx Biopharma Inc?

ChartMill assigns a valuation rating of 1 / 10 to Azurrx Biopharma Inc (AZRX). This can be considered as Overvalued.


Can you provide the profitability details for Azurrx Biopharma Inc?

Azurrx Biopharma Inc (AZRX) has a profitability rating of 1 / 10.


What is the earnings growth outlook for Azurrx Biopharma Inc?

The Earnings per Share (EPS) of Azurrx Biopharma Inc (AZRX) is expected to grow by 52.24% in the next year.


How sustainable is the dividend of Azurrx Biopharma Inc (AZRX) stock?

The dividend rating of Azurrx Biopharma Inc (AZRX) is 0 / 10 and the dividend payout ratio is 0%.